Andere talen Amicus Therapeutics, Inc.

Aandelen

FOLD

US03152W1099

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
10,43 ^USD	+4,40%		-1,04%	-26,50%

18/03	AMICUS THERAPEUTICS, INC. : JPMorgan Chase nog altijd een koopadvies	ZM
05/03	Insider van Amicus Therapeutics verkocht aandelen ter waarde van $389.543, volgens een recent SEC-document	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024	13:01
Amicus Therapeutics : ESG Report	20/03
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report	20/03
Amicus Therapeutics Insider Sold Shares Worth $389,543, According to a Recent SEC Filing	05/03
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024	04/03
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024	01/03
Amicus Therapeutics Swings to Q4 Earnings, Revenue Rises	28/02
Earnings Flash (FOLD) AMICUS THERAPEUTICS Posts Q4 EPS $0.01, vs. Street Est of $-0.04	28/02
Amicus Therapeutics, Inc. Provides Earnings Guidance for the Year 2024	28/02
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates	28/02
Amicus Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Amicus Therapeutics : Fourth Quarter and Full Year 2023 Results Conference Call and Webcast	28/02
Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024	15/02
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti + Opfolda at the 20th Annual WORLDSymposium	09/02
Amicus Therapeutics Insider Sold Shares Worth $390,018, According to a Recent SEC Filing	08/02
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™	08/02
Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024	01/02
Amicus Therapeutics Insider Sold Shares Worth $683,958, According to a Recent SEC Filing	24/01
Amicus Therapeutics Insider Sold Shares Worth $404,106, According to a Recent SEC Filing	18/01
Amicus Therapeutics Insider Sold Shares Worth $934,659, According to a Recent SEC Filing	12/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Amicus Therapeutics, Inc.

Aandelen

FOLD

US03152W1099

Andere talen

Filters